by CCHR National Affairs Office | May 31, 2023
Research sheds new light on the rising rates of suicidal behavior among teens. Patients taking antidepressants are at the greatest risk of self-harm, including suicidal thoughts and actions, in the weeks immediately after first starting on the drugs, a new...
by CCHR National Affairs Office | May 25, 2023
Advisory adds to concerns that there is insufficient benefit to offset the risk of serious side effects when taking or discontinuing antidepressants. Researchers are advising primary care doctors not to prescribe antidepressants to patients with mild to moderate...
by CCHR National Affairs Office | May 18, 2023
New warning cites high potentital for abuse and misuse of ADHD drugs that can lead to addiction, overdose, and death. The U.S. Food and Drug Administration (FDA) is requiring new warnings in the prescribing information for stimulant drugs used to treat so-called...
by CCHR National Affairs Office | May 10, 2023
Recent research found no benefit to patients’ mental health or any lower risk of suicides from involuntary psychiatric treatment. As National Mental Health Awareness Month draws attention to the importance of good mental health, the Citizens Commission on Human Rights...
by CCHR National Affairs Office | Apr 27, 2023
Another new study found as many as one in four students surveyed at middle schools and high schools reported misusing ADHD drugs in the previous year. A new study found that nearly half of adults using psychostimulant drugs for behavior termed attention-deficit...
